Full Breakdown
Long Island Mother Sues Pfizer Over Brain Tumor Linked to Depo-Provera
12/8/2025, 11:09:55 PM
Central Narrative: Lawsuit Against Pfizer
Elizabeth Fleurisma, a 33-year-old mother from Centereach, Long Island, is suing Pfizer, the manufacturer of Depo-Provera, after developing a brain tumor she believes is linked to her long-term use of the contraceptive. Fleurisma's case is part of a larger wave of lawsuits alleging that Pfizer failed to adequately warn users about the risks associated with the drug, particularly the potential for developing meningiomas, a type of brain tumor.
Background on Depo-Provera
Depo-Provera is a contraceptive injection containing the hormone progestin, administered every three months to prevent pregnancy. It is estimated that nearly 25% of sexually active women have used this method. Research indicates that prolonged use of certain progestins, including medroxyprogesterone acetate found in Depo-Provera, significantly increases the risk of developing intracranial meningiomas. Fleurisma's lawsuit cites historical knowledge of the relationship between sex hormones and meningiomas dating back to the 1920s, with scientific studies linking progestin to tumor development.
Health Impact and Personal Struggles
Fleurisma began using Depo-Provera in 2014 and experienced no issues until early 2023, when she began suffering from severe headaches and fatigue. Following a hospital visit, she was diagnosed with a brain tumor the size of a lime, leading to a 16-hour craniotomy in July 2023 at Stony Brook University Hospital. Despite the surgery, a portion of the tumor remains, necessitating extensive radiation treatment. Fleurisma continues to face ongoing health challenges, including vision problems, headaches, and nausea, which have significantly impacted her daily life and ability to care for her son.
Legal Action and Allegations
Fleurisma is one of 75 New Yorkers suing Pfizer, with over 1,700 lawsuits filed in federal court alleging that the company knowingly concealed the risks associated with Depo-Provera to protect its profits. Fleurisma's attorney, Ellen Relkin, noted that her tumor is the largest among the cases she has seen. Pfizer has publicly stated that it believes the claims are without merit and intends to vigorously defend itself, asserting that Depo-Provera remains a safe and effective option for reproductive health.
Official Statements & Responses
Pfizer maintains that it stands behind the safety and efficacy of Depo-Provera, which has been used by millions of women worldwide. The company has requested the U.S. Food and Drug Administration (FDA) to add warnings regarding the potential link to meningiomas but has faced rejection from the FDA, which stated that existing observational studies do not support such warnings.
Criticism & Opposition
Critics argue that Pfizer's failure to include warnings about meningiomas on Depo-Provera's label constitutes negligence, particularly given the historical understanding of the risks associated with progestin. Fleurisma's lawsuit aims to raise awareness among women about the importance of questioning their health choices and advocating for themselves.
Verbatim Quotes
“I’ve filed cases on behalf of about 150 women and have many other clients that we’re still evaluating, and Elizabeth’s tumor is the largest of all the ones I’ve seen,” — Ellen Relkin, Attorney
“When I came out of surgery, when I came home, it’s almost like I didn’t even know my environment,” — Elizabeth Fleurisma
“Fleurisma stopped taking Depo-Provera in 2023 on the advice of her neurosurgeon.” — Elizabeth Fleurisma
What's Next
Fleurisma continues her recovery while pursuing her lawsuit against Pfizer, hoping to empower other women to speak up about their health concerns. The outcome of her case, along with others, may influence future regulations and warnings regarding Depo-Provera and similar contraceptives.
